Injections frequency and health care costs in patients treated with aflibercept compared to ranibizumab: new real-life evidence from Switzerland.
about
Injections frequency and health care costs in patients treated with aflibercept compared to ranibizumab: new real-life evidence from Switzerland.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Injections frequency and healt ...... ife evidence from Switzerland.
@en
Injections frequency and healt ...... ife evidence from Switzerland.
@nl
type
label
Injections frequency and healt ...... ife evidence from Switzerland.
@en
Injections frequency and healt ...... ife evidence from Switzerland.
@nl
prefLabel
Injections frequency and healt ...... ife evidence from Switzerland.
@en
Injections frequency and healt ...... ife evidence from Switzerland.
@nl
P2093
P2860
P1433
P1476
Injections frequency and healt ...... ife evidence from Switzerland.
@en
P2093
Lucas M Bachmann
Martin K Schmid
Oliver Reich
P2860
P2888
P356
10.1186/S12886-017-0617-X
P577
2017-12-04T00:00:00Z
P6179
1093162727